Cargando…
Reply to “Novaferon, treatment in COVID-19 patients”
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687364/ https://www.ncbi.nlm.nih.gov/pubmed/33248243 http://dx.doi.org/10.1016/j.ijid.2020.11.179 |
| _version_ | 1783613501094232064 |
|---|---|
| author | Zheng, Fang Zhou, Yanwen Zhou, Zhiguo Ye, Fei Huang, Baoying Huang, Yaxiong Ma, Jing Zuo, Qi Tan, Xin Xie, Jun Niu, Peihua Wang, Wenlong Xu, Yun Peng, Feng Zhou, Ning Cai, Chunlin Tang, Wei Xiao, Xinqiang Li, Yi Zhou, Zhiguang Jiang, Yongfang Xie, Yuanlin Tan, Wenjie Gong, Guozhong |
| author_facet | Zheng, Fang Zhou, Yanwen Zhou, Zhiguo Ye, Fei Huang, Baoying Huang, Yaxiong Ma, Jing Zuo, Qi Tan, Xin Xie, Jun Niu, Peihua Wang, Wenlong Xu, Yun Peng, Feng Zhou, Ning Cai, Chunlin Tang, Wei Xiao, Xinqiang Li, Yi Zhou, Zhiguang Jiang, Yongfang Xie, Yuanlin Tan, Wenjie Gong, Guozhong |
| author_sort | Zheng, Fang |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7687364 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-76873642020-11-25 Reply to “Novaferon, treatment in COVID-19 patients” Zheng, Fang Zhou, Yanwen Zhou, Zhiguo Ye, Fei Huang, Baoying Huang, Yaxiong Ma, Jing Zuo, Qi Tan, Xin Xie, Jun Niu, Peihua Wang, Wenlong Xu, Yun Peng, Feng Zhou, Ning Cai, Chunlin Tang, Wei Xiao, Xinqiang Li, Yi Zhou, Zhiguang Jiang, Yongfang Xie, Yuanlin Tan, Wenjie Gong, Guozhong Int J Infect Dis Letter to the Editor The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021-02 2020-11-25 /pmc/articles/PMC7687364/ /pubmed/33248243 http://dx.doi.org/10.1016/j.ijid.2020.11.179 Text en © 2020 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Zheng, Fang Zhou, Yanwen Zhou, Zhiguo Ye, Fei Huang, Baoying Huang, Yaxiong Ma, Jing Zuo, Qi Tan, Xin Xie, Jun Niu, Peihua Wang, Wenlong Xu, Yun Peng, Feng Zhou, Ning Cai, Chunlin Tang, Wei Xiao, Xinqiang Li, Yi Zhou, Zhiguang Jiang, Yongfang Xie, Yuanlin Tan, Wenjie Gong, Guozhong Reply to “Novaferon, treatment in COVID-19 patients” |
| title | Reply to “Novaferon, treatment in COVID-19 patients” |
| title_full | Reply to “Novaferon, treatment in COVID-19 patients” |
| title_fullStr | Reply to “Novaferon, treatment in COVID-19 patients” |
| title_full_unstemmed | Reply to “Novaferon, treatment in COVID-19 patients” |
| title_short | Reply to “Novaferon, treatment in COVID-19 patients” |
| title_sort | reply to “novaferon, treatment in covid-19 patients” |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687364/ https://www.ncbi.nlm.nih.gov/pubmed/33248243 http://dx.doi.org/10.1016/j.ijid.2020.11.179 |
| work_keys_str_mv | AT zhengfang replytonovaferontreatmentincovid19patients AT zhouyanwen replytonovaferontreatmentincovid19patients AT zhouzhiguo replytonovaferontreatmentincovid19patients AT yefei replytonovaferontreatmentincovid19patients AT huangbaoying replytonovaferontreatmentincovid19patients AT huangyaxiong replytonovaferontreatmentincovid19patients AT majing replytonovaferontreatmentincovid19patients AT zuoqi replytonovaferontreatmentincovid19patients AT tanxin replytonovaferontreatmentincovid19patients AT xiejun replytonovaferontreatmentincovid19patients AT niupeihua replytonovaferontreatmentincovid19patients AT wangwenlong replytonovaferontreatmentincovid19patients AT xuyun replytonovaferontreatmentincovid19patients AT pengfeng replytonovaferontreatmentincovid19patients AT zhouning replytonovaferontreatmentincovid19patients AT caichunlin replytonovaferontreatmentincovid19patients AT tangwei replytonovaferontreatmentincovid19patients AT xiaoxinqiang replytonovaferontreatmentincovid19patients AT liyi replytonovaferontreatmentincovid19patients AT zhouzhiguang replytonovaferontreatmentincovid19patients AT jiangyongfang replytonovaferontreatmentincovid19patients AT xieyuanlin replytonovaferontreatmentincovid19patients AT tanwenjie replytonovaferontreatmentincovid19patients AT gongguozhong replytonovaferontreatmentincovid19patients |